Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 205 to 209 of 209 entries
Sorted by: Best Match Show Resources per page
Another Case of Lisinopril-Induced Acute Pancreatitis.

Cureus

Baum J, Walfish A, Fenster M, Miller Y, Kresch M.
PMID: 34912629
Cureus. 2021 Nov 11;13(11):e19488. doi: 10.7759/cureus.19488. eCollection 2021 Nov.

Lisinopril as a cause for acute drug-induced pancreatitis is an emerging phenomenon that due to its generally low-risk profile often goes unnoticed. The true incidence of drug-induced pancreatitis is unknown, probably because of its nonrecognition among differential diagnosis. Only...

Cite
Baum J, Walfish A, Fenster M, et al. Another Case of Lisinopril-Induced Acute Pancreatitis. Cureus. 2021;13(11):e19488doi: 10.7759/cureus.19488.
Baum, J., Walfish, A., Fenster, M., Miller, Y., & Kresch, M. (2021). Another Case of Lisinopril-Induced Acute Pancreatitis. Cureus, 13(11), e19488. https://doi.org/10.7759/cureus.19488
Baum, Jeffrey, et al. "Another Case of Lisinopril-Induced Acute Pancreatitis." Cureus vol. 13,11 (2021): e19488. doi: https://doi.org/10.7759/cureus.19488
Baum J, Walfish A, Fenster M, Miller Y, Kresch M. Another Case of Lisinopril-Induced Acute Pancreatitis. Cureus. 2021 Nov 11;13(11):e19488. doi: 10.7759/cureus.19488. eCollection 2021 Nov. PMID: 34912629; PMCID: PMC8664365.
Copy Download .nbib Format: NLM
Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes.

Frontiers in pharmacology

Gasperetti T, Miller T, Gao F, Narayanan J, Jacobs ER, Szabo A, Cox GN, Orschell CM, Fish BL, Medhora M.
PMID: 34079456
Front Pharmacol. 2021 May 17;12:634477. doi: 10.3389/fphar.2021.634477. eCollection 2021.

There is a need for countermeasures to mitigate lethal acute radiation syndrome (ARS) and delayed effects of acute radiation exposure (DEARE). In WAG/RijCmcr rats, ARS occurs by 30-days following total body irradiation (TBI), and manifests as potentially lethal gastrointestinal...

Cite
Gasperetti T, Miller T, Gao F, et al. Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Front Pharmacol. 2021;12:634477doi: 10.3389/fphar.2021.634477.
Gasperetti, T., Miller, T., Gao, F., Narayanan, J., Jacobs, E. R., Szabo, A., Cox, G. N., Orschell, C. M., Fish, B. L., & Medhora, M. (2021). Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Frontiers in pharmacology, 12634477. https://doi.org/10.3389/fphar.2021.634477
Gasperetti, Tracy, et al. "Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes." Frontiers in pharmacology vol. 12 (2021): 634477. doi: https://doi.org/10.3389/fphar.2021.634477
Gasperetti T, Miller T, Gao F, Narayanan J, Jacobs ER, Szabo A, Cox GN, Orschell CM, Fish BL, Medhora M. Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Front Pharmacol. 2021 May 17;12:634477. doi: 10.3389/fphar.2021.634477. eCollection 2021. PMID: 34079456; PMCID: PMC8165380.
Copy Download .nbib Format: NLM
ACE Inhibitor Induced Isolated Angioedema of the Small Bowel: A Rare Complication of a Common Medication.

Case reports in emergency medicine

Squillante MD, Trujillo A, Norton J, Bansal S, Dragoo D.
PMID: 33628527
Case Rep Emerg Med. 2021 Feb 13;2021:8853755. doi: 10.1155/2021/8853755. eCollection 2021.

Angioedema is a subcutaneous or submucosal tissue swelling due to capillary leakage and transudation of fluid into the interstitial tissue. It can be localized or generalized as part of a widespread reaction known as anaphylaxis. Millions of people in...

Cite
Squillante MD, Trujillo A, Norton J, et al. ACE Inhibitor Induced Isolated Angioedema of the Small Bowel: A Rare Complication of a Common Medication. Case Rep Emerg Med. 2021;2021:8853755doi: 10.1155/2021/8853755.
Squillante, M. D., Trujillo, A., Norton, J., Bansal, S., & Dragoo, D. (2021). ACE Inhibitor Induced Isolated Angioedema of the Small Bowel: A Rare Complication of a Common Medication. Case reports in emergency medicine, 20218853755. https://doi.org/10.1155/2021/8853755
Squillante, Marc D, et al. "ACE Inhibitor Induced Isolated Angioedema of the Small Bowel: A Rare Complication of a Common Medication." Case reports in emergency medicine vol. 2021 (2021): 8853755. doi: https://doi.org/10.1155/2021/8853755
Squillante MD, Trujillo A, Norton J, Bansal S, Dragoo D. ACE Inhibitor Induced Isolated Angioedema of the Small Bowel: A Rare Complication of a Common Medication. Case Rep Emerg Med. 2021 Feb 13;2021:8853755. doi: 10.1155/2021/8853755. eCollection 2021. PMID: 33628527; PMCID: PMC7896855.
Copy Download .nbib Format: NLM
Clofibrate, a Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride-Induced Toxicity.

Biological trace element research

Oyagbemi AA, Adejumobi OA, Jarikre TA, Ajani OS, Asenuga ER, Gbadamosi IT, Adedapo ADA, Aro AO, Ogunpolu BS, Hassan FO, Falayi OO, Ogunmiluyi IO, Omobowale TO, Arojojoye OA, Ola-Davies OE, Saba AB, Adedapo AA, Emikpe BO, Oyeyemi MO, Nkadimeng SM, McGaw LJ, Kayoka-Kabongo PN, Oguntibeju OO, Yakubu MA.
PMID: 33893992
Biol Trace Elem Res. 2021 Apr 24; doi: 10.1007/s12011-021-02722-1. Epub 2021 Apr 24.

Sodium fluoride (NaF) is one of the neglected environmental pollutants. It is ubiquitously found in the soil, water, and environment. Interestingly, fluoride has been extensively utilized for prevention of dental caries and tartar formation, and may be added to...

Cite
Oyagbemi AA, Adejumobi OA, Jarikre TA, et al. Clofibrate, a Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride-Induced Toxicity. Biol Trace Elem Res. 2021;doi: 10.1007/s12011-021-02722-1.
Oyagbemi, A. A., Adejumobi, O. A., Jarikre, T. A., Ajani, O. S., Asenuga, E. R., Gbadamosi, I. T., Adedapo, A. D. A., Aro, A. O., Ogunpolu, B. S., Hassan, F. O., Falayi, O. O., Ogunmiluyi, I. O., Omobowale, T. O., Arojojoye, O. A., Ola-Davies, O. E., Saba, A. B., Adedapo, A. A., Emikpe, B. O., Oyeyemi, M. O., Nkadimeng, S. M., McGaw, L. J., Kayoka-Kabongo, P. N., Oguntibeju, O. O., & Yakubu, M. A. (2021). Clofibrate, a Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride-Induced Toxicity. Biological trace element research, . https://doi.org/10.1007/s12011-021-02722-1
Oyagbemi, Ademola Adetokunbo, et al. "Clofibrate, a Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride-Induced Toxicity." Biological trace element research vol. (2021). doi: https://doi.org/10.1007/s12011-021-02722-1
Oyagbemi AA, Adejumobi OA, Jarikre TA, Ajani OS, Asenuga ER, Gbadamosi IT, Adedapo ADA, Aro AO, Ogunpolu BS, Hassan FO, Falayi OO, Ogunmiluyi IO, Omobowale TO, Arojojoye OA, Ola-Davies OE, Saba AB, Adedapo AA, Emikpe BO, Oyeyemi MO, Nkadimeng SM, McGaw LJ, Kayoka-Kabongo PN, Oguntibeju OO, Yakubu MA. Clofibrate, a Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride-Induced Toxicity. Biol Trace Elem Res. 2021 Apr 24; doi: 10.1007/s12011-021-02722-1. Epub 2021 Apr 24. PMID: 33893992.
Copy Download .nbib Format: NLM
Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.

BMC nephrology

Okyere P, Ephraim RKD, Okyere I, Attakorah J, Serwaa D, Essuman G, Abaka-Yawson A, Adoba P.
PMID: 33910506
BMC Nephrol. 2021 Apr 28;22(1):156. doi: 10.1186/s12882-021-02336-8.

BACKGROUND: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the commonest of the hereditary kidney diseases and mostly ensues in utero with signs delayed until after several decades. This study assessed the demographic, diagnostic (clinical and biochemical features) and therapeutic...

Cite
Okyere P, Ephraim RKD, Okyere I, et al. Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana. BMC Nephrol. 2021;22(1):156doi: 10.1186/s12882-021-02336-8.
Okyere, P., Ephraim, R. K. D., Okyere, I., Attakorah, J., Serwaa, D., Essuman, G., Abaka-Yawson, A., & Adoba, P. (2021). Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana. BMC nephrology, 22(1), 156. https://doi.org/10.1186/s12882-021-02336-8
Okyere, Perditer, et al. "Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana." BMC nephrology vol. 22,1 (2021): 156. doi: https://doi.org/10.1186/s12882-021-02336-8
Okyere P, Ephraim RKD, Okyere I, Attakorah J, Serwaa D, Essuman G, Abaka-Yawson A, Adoba P. Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana. BMC Nephrol. 2021 Apr 28;22(1):156. doi: 10.1186/s12882-021-02336-8. PMID: 33910506; PMCID: PMC8080413.
Copy Download .nbib Format: NLM
Showing 205 to 209 of 209 entries